Skip to main content

1 Result(s)

within Tsuyoshi Onishi Remove this filter

and

  1. No Access

    Article

    The impact of hyporesponsiveness to erythropoietin-stimulating agents on time-dependent mortality risk among CKD stage 5D patients: a single-center cohort study

    Hyporesponsiveness to a large dose of erythropoietin-stimulating agents (ESA) could increase mortality risk among chronic kidney disease patients. This study aimed to assess a safe dose of ESA and the impact o...

    Junichi Ishigami, Tsuyoshi Onishi, Satomi Shikuma… in Clinical and Experimental Nephrology (2013)